Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-05 Sale |
2024-02-06 6:29 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
6,212 | $4.86 | $30,190 | 380,356 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:26 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
19,642 | $4.86 | $95,460 | 1,144,601 (Indirect Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:03 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
6,433 | $4.95 | $31,843 | 139,932 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:02 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
7,764 | $4.95 | $38,432 | 92,767 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:01 pm |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
6,831 | $4.95 | $33,813 | 109,218 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:01 pm |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
5,147 | $4.95 | $25,478 | 89,619 (Direct) |
View |
| 2024-01-31 Sale |
2024-02-02 7:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
18,338 | $4.95 | $90,773 | 434,443 (Indirect Direct) |
View |
| 2023-12-14 Purchase |
2023-12-18 4:52 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
1,538,461 | $3.25 | $4,999,998 | 7,660,550 (Indirect) |
View |
| 2023-08-30 Purchase |
2023-09-05 08:27 am |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
6,500 | $3.81 | $24,765 | 452,781 (Indirect Direct) |
View |
| 2023-07-07 Sale |
2023-07-11 8:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
832 | $4.93 | $4,102 | 100,531 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:38 pm |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
5,829 | $4.24 | $24,715 | 94,766 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:33 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
6,416 | $4.24 | $27,204 | 101,363 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:32 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
6,476 | $4.24 | $27,458 | 139,387 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:31 pm |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
6,181 | $4.24 | $26,207 | 109,071 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 7:29 pm |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
19,669 | $4.24 | $83,397 | 446,281 (Direct) |
View |
| 2022-11-07 Purchase |
2022-11-09 4:48 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
7,328 | $3.5 | $25,648 | 6,122,089 (Indirect) |
View |
| 2022-10-10 Purchase |
2022-10-12 4:34 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
20,000 | $3.9487 | $78,975 | 6,114,761 (Indirect) |
View |
| 2022-09-27 Purchase |
2022-09-29 7:51 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
150,000 | $4.5949 | $689,230 | 6,094,761 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-03 Option Award |
2024-02-06 6:29 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
246,636 | $0 | 380,356 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:26 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
729,800 | $0 | 1,144,601 (Direct) |
View |
| 2023-08-02 Option Award |
2023-08-18 8:45 pm |
N/A 2033-08-01 |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director |
17,350 | $0 | 17,350 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 5:18 pm |
N/A 2033-07-09 |
OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:09 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director |
48,000 | $0 | 96,464 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:08 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director |
48,000 | $0 | 61,433 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:05 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director |
48,000 | $0 | 56,933 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:05 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director |
48,000 | $0 | 156,402 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:03 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director |
48,000 | $0 | 56,933 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 7:02 pm |
N/A 2033-06-13 |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director |
48,000 | $0 | 95,933 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:36 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
177,777 | $0 | 233,928 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:35 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
222,223 | $0 | 281,919 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:34 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
272,223 | $0 | 324,446 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:33 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer |
222,223 | $0 | 312,530 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 7:32 pm |
N/A 2033-01-29 |
OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO |
713,200 | $0 | 1,002,850 (Direct) |
View |
| 2022-10-17 Option Award |
2022-10-18 5:12 pm |
N/A 2032-10-16 |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-14 9:04 pm |
N/A 2032-10-12 |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
7,000 | $0 | 7,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-15 8:01 pm |
N/A 2032-06-30 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
56,667 | $0 | 122,223 (Direct) |
View |
Ownership |
2022-07-11 8:55 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
0 | $0 | 302,223 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 8:10 pm |
N/A 2032-06-15 |
OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director |
35,733 | $0 | 35,733 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 8:09 pm |
N/A 2032-06-15 |
OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director |
35,733 | $0 | 40,233 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 8:08 pm |
N/A 2032-06-15 |
OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director |
35,733 | $0 | 75,264 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 8:07 pm |
N/A 2032-06-15 |
OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director |
35,733 | $0 | 135,202 (Direct) |
View |